March 28 Moving to offset shortages of a common
saline used in hospitals and dialysis centers, the U.S. Food and
Drug Administration said on Friday that it will temporarily
allow Fresenius Kabi USA LLC to distribute normal saline from
its manufacturing facility in Norway.
The FDA said the initial shipments would help but not
resolve shortages of 0.9 percent sodium chloride injection, also
known as normal saline. The drug is widely used to treat
patients with dehydration and other medical conditions.
The FDA said it is continuing to work with Baxter Healthcare
Corp, B.Braun Medical Inc. and Hospira Inc to
restore their supplies to hospitals and health clinics. The
agency is also working with Fresenius Medical Care which
supplies the drug to dialysis centers.
(Reporting by Toni Clarke in Washington; Editing by David